Suvretta Capital Management’s Zura Bio ZURA Stock Holding History

Suvretta Capital Management’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$53.9M	Buy	9,067,001 +3,500,000	+63%	+$21.1M	1.38%	28
2025 Q4	$29.2M	Buy	5,567,001 +94,110	+2%	+$372K	0.6%	47
2025 Q3	$23.7M	Buy	5,472,891 +611,952	+13%	+$1.1M	0.61%	50
2025 Q2	$5.1M	Hold	4,860,939	–	–	0.15%	62
2025 Q1	$6.27M	Hold	4,860,939	–	–	0.23%	61
2024 Q4	$12.2M	Hold	4,860,939	–	–	0.41%	53
2024 Q3	$19.7M	Hold	4,860,939	–	–	0.63%	48
2024 Q2	$17M	Buy	4,860,939 +2,010,939	+71%	+$8.2M	0.63%	42
2024 Q1	$7.32M	Hold	2,850,000	–	–	0.27%	57
2023 Q4	$13.3M	Hold	2,850,000	–	–	0.6%	43
2023 Q3	$18.8M	Hold	2,850,000	–	–	1.02%	31
2023 Q2	$23.4M	Buy	+2,850,000	New	+$22.9M	1.25%	29

Other funds holding ZURA

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Suvretta Capital Management's ZURA Position: Q1 2026 in Review

Suvretta Capital Management increased its Zura Bio (ZURA) stake by 63% in Q1 2026, buying an estimated $21.1M and bringing the position to 9,067,001 shares worth $53.9M. The position accounts for 1.38% of the portfolio, ranked #28.

Suvretta Capital Management first reported a position in ZURA in Q2 2023 and has held it in 12 quarters since. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

Suvretta Capital Management held 9,067,001 shares of Zura Bio worth $53.9M as of Q1 2026.
Suvretta Capital Management bought 3,500,000 Zura Bio shares in Q1 2026, an estimated $21.1M.
Zura Bio made up 1.38% of Suvretta Capital Management's portfolio in Q1 2026, its #28 holding.
Suvretta Capital Management first reported a position in Zura Bio in Q2 2023 and has held it in 12 quarters since.
94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Suvretta Capital Management's 13F filing for Q1 2026, filed 15 May 2026.